Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Hum Mutat. 2010 Sep;31(9):1080-8. doi: 10.1002/humu.21322.
Hyper-IgM syndrome and Common Variable Immunodeficiency are heterogeneous disorders characterized by a predisposition to serious infection and impaired or absent neutralizing antibody responses. Although a number of single gene defects have been associated with these immune deficiency disorders, the genetic basis of many cases is not known. To facilitate mutation screening in patients with these syndromes, we have developed a custom 300-kb resequencing array, the Hyper-IgM/CVID chip, which interrogates 1,576 coding exons and intron-exon junction regions from 148 genes implicated in B-cell development and immunoglobulin isotype switching. Genomic DNAs extracted from patients were hybridized to the array using a high-throughput protocol for target sequence amplification, pooling, and hybridization. A Web-based application, SNP Explorer, was developed to directly analyze and visualize the single nucleotide polymorphism (SNP) annotation and for quality filtering. Several mutations in known disease-susceptibility genes such as CD40LG, TNFRSF13B, IKBKG, AICDA, as well as rare nucleotide changes in other genes such as TRAF3IP2, were identified in patient DNA samples and validated by direct sequencing. We conclude that the Hyper-IgM/CVID chip combined with SNP Explorer may provide a cost-effective tool for high-throughput discovery of novel mutations among hundreds of disease-relevant genes in patients with inherited antibody deficiency.
高免疫球蛋白 M 血症和常见可变免疫缺陷是两种异质性疾病,其特征为易发生严重感染和中和抗体应答受损或缺失。虽然许多单基因缺陷与这些免疫缺陷疾病相关,但许多病例的遗传基础尚不清楚。为了便于对这些综合征患者进行突变筛查,我们开发了一种定制的 300kb 重测序阵列,即高免疫球蛋白血症/常见可变免疫缺陷芯片,该阵列检测了 148 个与 B 细胞发育和免疫球蛋白同种型转换相关的基因的 1576 个编码外显子和内含子-外显子交界区。使用高通量方案对从患者中提取的基因组 DNA 进行靶序列扩增、混合和杂交,然后将其杂交到阵列上。开发了一个名为 SNP 探索者(SNP Explorer)的基于网络的应用程序,用于直接分析和可视化单核苷酸多态性(SNP)注释,并进行质量过滤。在患者的 DNA 样本中鉴定出了一些已知疾病易感性基因(如 CD40LG、TNFRSF13B、IKBKG、AICDA)中的突变,以及其他基因(如 TRAF3IP2)中的罕见核苷酸变化,并通过直接测序进行了验证。我们的结论是,高免疫球蛋白血症/常见可变免疫缺陷芯片与 SNP 探索者结合使用可能为高通量发现遗传性抗体缺陷患者数百个相关疾病基因中的新突变提供一种具有成本效益的工具。